Promises And Pitfalls Of Regenerative Therapies For Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, And Exosomes
January 2025
in “
Open Science Framework
”
TLDR Current evidence is insufficient to fully endorse regenerative therapies for hair loss.
Regenerative therapies for androgenetic alopecia, including platelet-rich plasma, photobiomodulation, stem cells, and exosomes, are gaining attention but face challenges such as commercialization, insufficient high-quality evidence, and changing regulations. This review critically examines studies from 2020 to 2025, highlighting the need for more robust research to validate these treatments' efficacy and safety. Despite their potential, the current evidence is not yet strong enough to fully endorse these therapies for widespread clinical use.